Nature Communications

Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial

2026-03-14

Full text

DOI https://doi.org/10.1038/s41467-026-69965-1